What’s new?The U.S. Food and Drug Administration today approved a supplemental application for Gardasil 9 (Human Papillomavirus (HPV) 9-valent Vaccine, Recombinant) expanding the approved use of the vaccine from males and females aged 9 through 26 years to include men and women aged 27 through 45 ...